 |
Open for inclusion |
A first-in-human, multicenter, open-label, phase 1 study in patients with advanced and/or refractoryCancer type: Solide tumores Phase: I Principal Investigator: Yachnin Jeffrey Country: SE Keywords: Swede, Stockholm, ATOR-1015 Status: Open for inclusion Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT03782467?term=ator-1015&rank=1 |